These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11744826)

  • 21. Prevalence of Parkinson's disease in Baskale, Turkey: a population based study.
    Durmus H; Gokalp MA; Hanagasi HA
    Neurol Sci; 2015 Mar; 36(3):411-3. PubMed ID: 25351343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-control study of Parkinson's disease in urban population of southern Israel.
    Herishanu YO; Medvedovski M; Goldsmith JR; Kordysh E
    Can J Neurol Sci; 2001 May; 28(2):144-7. PubMed ID: 11383940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer incidence and risks in selected agricultural settlements in the Negev of Israel.
    Avnon L; Oryan I; Kordysh E; Goldsmith J; Sobel R; Friger M
    Arch Environ Health; 1998; 53(5):336-43. PubMed ID: 9766478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer incidence in kibbutzim in Israel.
    Lieberman D; Katz L; Herman J; Epstein L
    Isr J Med Sci; 1982 Aug; 18(8):849-53. PubMed ID: 7118531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of ulcerative colitis in the Israeli kibbutz population.
    Niv Y; Abukasis G
    J Clin Gastroenterol; 1991 Feb; 13(1):98-101. PubMed ID: 2007757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease.
    Giladi N; Mirelman A; Thaler A; Bar-Shira A; Gurevich T; Orr-Urtreger A
    J Neurol Sci; 2011 Nov; 310(1-2):17-20. PubMed ID: 21704337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β2-adrenoceptor agonists and antagonists and risk of Parkinson's disease.
    Gronich N; Abernethy DR; Auriel E; Lavi I; Rennert G; Saliba W
    Mov Disord; 2018 Sep; 33(9):1465-1471. PubMed ID: 30311974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dementia in Parkinson's disease: Is male gender a risk factor?
    Cereda E; Cilia R; Klersy C; Siri C; Pozzi B; Reali E; Colombo A; Zecchinelli AL; Mariani CB; Tesei S; Canesi M; Sacilotto G; Meucci N; Zini M; Isaias IU; Barichella M; Cassani E; Goldwurm S; Pezzoli G
    Parkinsonism Relat Disord; 2016 May; 26():67-72. PubMed ID: 26952697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Parkinson's disease: a population-based study in Portugal.
    Ferreira JJ; Gonçalves N; Valadas A; Januário C; Silva MR; Nogueira L; Vieira JLM; Lima AB
    Eur J Neurol; 2017 May; 24(5):748-750. PubMed ID: 28251720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographical variations in mortality from Parkinson's disease in Japan, 1977-1985.
    Imaizumi Y
    Acta Neurol Scand; 1995 May; 91(5):311-6. PubMed ID: 7639057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The earliest memory in individuals raised in either traditional and reformed kibbutz or outside the kibbutz.
    Harpaz-Rotem I; Hirst W
    Memory; 2005 Jan; 13(1):51-62. PubMed ID: 15724907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study.
    Peretz C; Gurel R; Rozani V; Gurevich T; El-Ad B; Tsamir J; Giladi N
    Parkinsonism Relat Disord; 2016 Jul; 28():68-72. PubMed ID: 27161827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of ulcerative colitis in Israel: a twenty-year survey.
    Birkenfeld S; Zvidi I; Hazazi R; Niv Y
    J Clin Gastroenterol; 2009 Sep; 43(8):743-6. PubMed ID: 19369888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental risk factors in Parkinson's disease.
    Kuopio AM; Marttila RJ; Helenius H; Rinne UK
    Mov Disord; 1999 Nov; 14(6):928-39. PubMed ID: 10584666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time trends in the prevalence and incidence of Parkinson's disease in Taiwan: A nationwide, population-based study.
    Liu WM; Wu RM; Lin JW; Liu YC; Chang CH; Lin CH
    J Formos Med Assoc; 2016 Jul; 115(7):531-8. PubMed ID: 26123636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease prevalence and the association with rurality and agricultural determinants.
    Ayton D; Ayton S; Barker AL; Bush AI; Warren N
    Parkinsonism Relat Disord; 2019 Apr; 61():198-202. PubMed ID: 30377035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mental health-related knowledge, attitudes and practices in two kibbutzim.
    Levav I; Shemesh A; Grinshpoon A; Aisenberg E; Shershevsky Y; Kohn R
    Soc Psychiatry Psychiatr Epidemiol; 2004 Sep; 39(9):758-64. PubMed ID: 15672298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Parkinson's disease in Bulgaria.
    Hristova D; Zachariev Z; Mateva N; Grozdev I
    Neuroepidemiology; 2010; 34(2):76-82. PubMed ID: 20016216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Israeli kibbutz as a venue for reduced disability in old age: lessons from the Cross-sectional and Longitudinal Aging Study (CALAS).
    Walter-Ginzburg A; Blumstein T; Guralnik JM
    Soc Sci Med; 2004 Jul; 59(2):389-403. PubMed ID: 15110428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community.
    Fall PA; Axelson O; Fredriksson M; Hansson G; Lindvall B; Olsson JE; Granérus AK
    J Clin Epidemiol; 1996 Jun; 49(6):637-41. PubMed ID: 8656224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.